Overview

Cardiac Surgery Neuroprotection Study in Elders

Status:
Completed

Trial end date:
2014-10-01

Target enrollment:

Participant gender:

Summary

The goal of this study is to determine the potential ability of intranasal insulin to prevent post-operative cognitive decline and post-operative delirium in an elderly cardiac surgery population.

Phase:

Phase 2

Details

Lead Sponsor:

Albert Einstein College of Medicine
Albert Einstein College of Medicine of Yeshiva University

Collaborator:

National Institute on Aging (NIA)

Treatments:

Insulin
Insulin Aspart
Insulin degludec, insulin aspart drug combination
Insulin, Globin Zinc
Insulin, Long-Acting